glp-1 clinical trials efficacy results from clinical comparing different Discover How GLP-1 Trials Are
Description
Lancet Diabetes Endocrinol 2021;9:653-62.ArticlePubMed 75
Cost-effectiveness analysis of liraglutide versus sitagliptin or exenatide in patients with inadequately controlled type 2 diabetes on oral antidiabetic drugs in Greece
Adequate protein: Helps maintain muscle mass during weight loss and supports satiety
[20] [9] If severe abdominal pain develops during GLP-1 agonist treatmentparticularly if it persists for several hours or is accompanied by repeated vomitingpatients should stop taking the medication and seek immediate medical assessment
Key Takeaways Many people with obesity need ongoing treatment even after reaching their target weight
These conditions are defined using body mass index (BMI), a measure that compares weight to height
